T-cell responses to cancer.
Lee
Peter P
PP
Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California 94305, USA.
D015703:Antigens, CD / Q000032:analysis / Q000378:metabolism; D000951:Antigens, Neoplasm / Q000276:immunology; D002469:Cell Separation / Q000379:methods; D016207:Cytokines / Q000032:analysis / Q000378:metabolism; D005434:Flow Cytometry / Q000379:methods; D020869:Gene Expression Profiling / Q000379:methods; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods; D016130:Immunophenotyping / Q000379:methods; D008198:Lymph Nodes / Q000473:pathology; D008213:Lymphocyte Activation / Q000276:immunology; D051907:Lysosomal Membrane Proteins; D009369:Neoplasms / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D016133:Polymerase Chain Reaction / Q000379:methods; D040081:Protein Array Analysis / Q000379:methods; D013194:Staining and Labeling / Q000379:methods; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D015703:Antigens, CD; D000951:Antigens, Neoplasm; D016207:Cytokines; D006680:HLA Antigens; D051907:Lysosomal Membrane Proteins